These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14503778)

  • 1. Randomised controlled trials (RCTs)--essentials.
    Chan YH
    Singapore Med J; 2003 Feb; 44(2):60-3. PubMed ID: 14503778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Design and conduct of randomized controlled trials (RCTs)].
    Park DH; Baik SK
    Korean J Hepatol; 2006 Sep; 12(3):309-14. PubMed ID: 16998284
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions?
    Kraemer HC; Robinson TN
    Contemp Clin Trials; 2005 Oct; 26(5):518-29. PubMed ID: 15993653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.
    Booth CM; Ohorodnyk P; Zhu L; Tu D; Meyer RM
    Eur J Cancer; 2011 Apr; 47(6):854-63. PubMed ID: 21296570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results.
    Manyonda I; Thakar RB; Ayers S
    BJOG; 2004 Jul; 111(7):760; author reply 760-1. PubMed ID: 15198771
    [No Abstract]   [Full Text] [Related]  

  • 8. How to perform a critical analysis of a randomised controlled trial.
    Estellat C; Torgerson DJ; Ravaud P
    Best Pract Res Clin Rheumatol; 2009 Apr; 23(2):291-303. PubMed ID: 19393572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trials in implant therapy: relationships among methodological, statistical, clinical, paratextual features and number of citations.
    Nieri M; Clauser C; Franceschi D; Pagliaro U; Saletta D; Pini-Prato G
    Clin Oral Implants Res; 2007 Aug; 18(4):419-31. PubMed ID: 17517060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Chen X
    Stat Med; 2005 May; 24(9):1449-52; author reply 1452. PubMed ID: 15812844
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the methodology in cluster randomized trials].
    Kramar A; Bonnetain F; Mathoulin-Pélissier S
    Bull Cancer; 2008 Dec; 95(12):1141-2. PubMed ID: 19108340
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostics for assumptions in moderate to large simple clinical trials: do they really help?
    Ganju J
    Stat Med; 2006 May; 25(10):1799-800. PubMed ID: 16639774
    [No Abstract]   [Full Text] [Related]  

  • 14. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate markers: back to the future.
    D'Agostino RB; Campbell MJ; Greenhouse JB
    Stat Med; 2006 Jan; 25(2):181-2. PubMed ID: 16381076
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fallacies in clinical cardiovascular trials.
    Swedberg K
    Heart; 2009 Sep; 95(17):1464-8. PubMed ID: 19684197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.